RhumbLine Advisers’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
RhumbLine Advisers's IRMD Position: Q3 2026 in Review
RhumbLine Advisers increased its iRadimed (IRMD) stake by 18% in Q3 2026, buying an estimated $208K and bringing the position to 15,005 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2119.
RhumbLine Advisers first reported a position in IRMD in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.32M in Q4 2025. 212 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.
- RhumbLine Advisers held 15,005 shares of iRadimed worth $1.29M as of Q3 2026.
- RhumbLine Advisers bought 2,315 iRadimed shares in Q3 2026, an estimated $208K.
- iRadimed made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #2119 holding.
- RhumbLine Advisers first reported a position in iRadimed in Q4 2021 and has held it in 20 quarters since.
- RhumbLine Advisers's iRadimed position peaked at $1.32M in Q4 2025.
- 212 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.